Sibutramine is an antiobesity drug which has also an inbitor effect on NE and 5HT reuptake pumps. These antidepressant pharmacodynamic properties of sibutramine has been proved by pre-clinical and clinical trials. Here, we want to report a 53 years old male patient who did not have any prior hypomanic or manic episodes had a mixed episode after a 3 months of antiobesity treatment by 30 mg/day sibutramine. Since sibutramine has an antidepressant activity drug which may cause affective or psychotic symptoms we wanted to highlight the importance of evaluating the mental and psychiatric status of patients during and prior to treatment
Objective: There are reports of alprazolam-induced hypomanidmania. Here is a case report of a patien...
Objective: This study examined the risk of antidepressant-induced manic switch in patients with bipo...
Objective: This case report highlights the clinical dilemmas encountered in deciding the diagnostic ...
Sibutramin obesite tedavisinde kullanılan serotonin, noradrenalin ve daha zayıf bir şekilde de dopam...
Background: Sibutramine is a weight loss agent recently withdrawn from the European market due to ca...
Objective: The objective of these 4 case reports is to highlight that psychotic symptom can occur du...
Obesity which has medical morbidity and psychological components has an increasing prevalence rate. ...
Sibutramine is a prohibited weight-reducing agent used in many weight-loss products, which has been ...
É descrito um caso de interação medicamentosa em um paciente de 30 anos, que fazia com sucesso um tr...
BACKGROUND: In this report, we describe a case of a patient with substance-induced anxiety disorder ...
Serotonin Syndrome (SS) is a potentially fatal iatrogenic condition that occurs as a result of an ov...
Objective: A rare case of induced hypomania was reported. Method: Patient was a 78-year-old Indian f...
Serotonin syndrome (SS) is a relatively rare but potentially life-threatening condition caused...
Methylphenidate is one of the classic amphetamines which can cause or exacerbate psychotic symptoms ...
Treatment with antidepressants can cause switching to mania or hypomania. Duloxetine is a novel sero...
Objective: There are reports of alprazolam-induced hypomanidmania. Here is a case report of a patien...
Objective: This study examined the risk of antidepressant-induced manic switch in patients with bipo...
Objective: This case report highlights the clinical dilemmas encountered in deciding the diagnostic ...
Sibutramin obesite tedavisinde kullanılan serotonin, noradrenalin ve daha zayıf bir şekilde de dopam...
Background: Sibutramine is a weight loss agent recently withdrawn from the European market due to ca...
Objective: The objective of these 4 case reports is to highlight that psychotic symptom can occur du...
Obesity which has medical morbidity and psychological components has an increasing prevalence rate. ...
Sibutramine is a prohibited weight-reducing agent used in many weight-loss products, which has been ...
É descrito um caso de interação medicamentosa em um paciente de 30 anos, que fazia com sucesso um tr...
BACKGROUND: In this report, we describe a case of a patient with substance-induced anxiety disorder ...
Serotonin Syndrome (SS) is a potentially fatal iatrogenic condition that occurs as a result of an ov...
Objective: A rare case of induced hypomania was reported. Method: Patient was a 78-year-old Indian f...
Serotonin syndrome (SS) is a relatively rare but potentially life-threatening condition caused...
Methylphenidate is one of the classic amphetamines which can cause or exacerbate psychotic symptoms ...
Treatment with antidepressants can cause switching to mania or hypomania. Duloxetine is a novel sero...
Objective: There are reports of alprazolam-induced hypomanidmania. Here is a case report of a patien...
Objective: This study examined the risk of antidepressant-induced manic switch in patients with bipo...
Objective: This case report highlights the clinical dilemmas encountered in deciding the diagnostic ...